HealthWarehouse(HEWA)
$0.090.00 (0.00%)
HEWA
HealthWarehouse financials statements
$0.09
At close:0.00 (0.00%)
Want to see HEWA full AI Analyst Report?
HealthWarehouse (HEWA) Ratios
3 Followers
HealthWarehouse Ratios
HEWA's free cash flow for Q2 2026 was $-389.46K. For the 2026 fiscal year, HEWA's free cash flow was increased by $6.00 and operating cash flow was $-389.47K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.74 | 0.56 | 0.40 | 0.63 | 0.83 |
| Quick Ratio | 0.60 | 0.40 | 0.29 | 0.51 | 0.75 |
| Cash Ratio | 0.38 | 0.21 | 0.12 | 0.26 | 0.65 |
| Solvency Ratio | 0.09 | 0.01 | -0.20 | -0.10 | -0.07 |
| Operating Cash Flow Ratio | 0.20 | 0.13 | -0.04 | -0.15 | 0.12 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 4.70 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -4.91M | $ -6.07M | $ -5.37M | $ -4.44M | $ -3.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.76 | 0.65 | 0.77 | 0.59 |
| Debt-to-Equity Ratio | -0.88 | -0.95 | -0.52 | -1.00 | -0.77 |
| Debt-to-Capital Ratio | -7.22 | -19.83 | -1.09 | 287.18 | -3.37 |
| Long-Term Debt-to-Capital Ratio | -1.65 | -2.40 | -0.98 | -14.44 | -3.37 |
| Financial Leverage Ratio | -1.78 | -1.25 | -0.80 | -1.31 | -1.30 |
| Debt Service Coverage Ratio | 11.90 | 0.87 | -8.40 | -3.43 | -1.51 |
| Interest Coverage Ratio | 5.72 | -0.39 | -10.68 | -4.78 | -2.06 |
| Debt to Market Cap | 0.33 | 0.68 | 0.26 | 0.29 | 0.28 |
| Interest Debt Per Share | 0.05 | 0.07 | 0.04 | 0.06 | 0.04 |
| Net Debt to EBITDA | 0.75 | 8.01 | -1.19 | -3.58 | 0.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.99% | 40.73% | 60.02% | 65.82% | 68.96% |
| EBIT Margin | 0.84% | -0.29% | -8.00% | -4.32% | -2.23% |
| EBITDA Margin | 1.90% | 1.01% | -6.29% | -3.08% | -1.39% |
| Operating Profit Margin | 0.84% | -0.28% | -8.00% | -4.32% | -2.23% |
| Pretax Profit Margin | 0.69% | -0.99% | -8.74% | -5.23% | -3.31% |
| Net Profit Margin | 0.54% | -0.99% | -8.74% | -5.25% | -3.55% |
| Continuous Operations Profit Margin | 0.54% | -0.99% | -8.74% | -5.25% | -3.55% |
| Net Income Per EBT | 77.94% | 100.00% | 100.00% | 100.40% | 107.21% |
| EBT Per EBIT | 82.52% | 358.96% | 109.37% | 120.93% | 148.49% |
| Return on Assets (ROA) | 4.51% | -6.60% | -55.28% | -24.00% | -15.81% |
| Return on Equity (ROE) | -8.02% | 8.25% | 44.27% | 31.38% | 20.55% |
| Return on Capital Employed (ROCE) | 541.82% | 26.97% | 117.94% | 894.32% | -136.86% |
| Return on Invested Capital (ROIC) | 129.42% | 47.86% | 128.07% | -7397.00% | -136.86% |
| Return on Tangible Assets | 4.66% | -6.98% | -62.14% | -25.76% | -15.81% |
| Earnings Yield | 4.28% | -7.54% | -23.29% | -9.67% | -7.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 42.70 | 36.26 | 33.35 | 21.41 | 108.80 |
| Payables Turnover | 26.90 | 15.72 | 9.00 | 7.68 | 7.46 |
| Inventory Turnover | 41.07 | 23.67 | 15.93 | 12.34 | 17.82 |
| Fixed Asset Turnover | 35.59 | 19.53 | 20.07 | 16.06 | 19.34 |
| Asset Turnover | 8.34 | 6.66 | 6.32 | 4.57 | 4.46 |
| Working Capital Turnover Ratio | -25.08 | -13.14 | -9.59 | -17.60 | -30.24 |
| Cash Conversion Cycle | 3.87 | 2.27 | -6.71 | -0.92 | -25.07 |
| Days of Sales Outstanding | 8.55 | 10.07 | 10.94 | 17.05 | 3.35 |
| Days of Inventory Outstanding | 8.89 | 15.42 | 22.92 | 29.58 | 20.49 |
| Days of Payables Outstanding | 13.57 | 23.21 | 40.57 | 47.55 | 48.91 |
| Operating Cycle | 17.43 | 25.49 | 33.86 | 46.63 | 23.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.01 | -0.00 | -0.01 | 0.01 |
| Free Cash Flow Per Share | 0.02 | 0.01 | -0.01 | -0.02 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | 12.16 | 5.04 | -0.53 | -1.22 | 4.61 |
| Capital Expenditure Coverage Ratio | 12.16 | 5.04 | -0.53 | -1.22 | 4.61 |
| Operating Cash Flow Coverage Ratio | 0.40 | 0.18 | -0.08 | -0.21 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.02 | -0.01 | -0.03 | 0.02 |
| Free Cash Flow Yield | 17.15% | 12.81% | -6.22% | -11.55% | 4.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -78.57 | -6.56 | -4.29 | -10.34 | -13.58 |
| Price-to-Sales (P/S) Ratio | 0.13 | 0.13 | 0.38 | 0.54 | 0.48 |
| Price-to-Book (P/B) Ratio | -1.88 | -1.09 | -1.90 | -3.24 | -2.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.83 | 7.81 | -16.07 | -8.65 | 24.78 |
| Price-to-Operating Cash Flow Ratio | 5.35 | 6.26 | -46.48 | -15.76 | 19.41 |
| Price-to-Earnings Growth (PEG) Ratio | 0.89 | 0.10 | -0.04 | -0.16 | 0.06 |
| Enterprise Value Multiple | 7.40 | 21.05 | -7.17 | -21.18 | -34.44 |
| Enterprise Value | 6.90M | 7.13M | 9.14M | 11.85M | 7.74M |
| EV to EBITDA | 7.40 | 21.05 | -7.17 | -21.18 | -34.44 |
| EV to Sales | 0.14 | 0.21 | 0.45 | 0.65 | 0.48 |
| EV to Free Cash Flow | 6.49 | 12.60 | -19.29 | -10.42 | 24.68 |
| EV to Operating Cash Flow | 5.95 | 10.10 | -55.77 | -18.97 | 19.33 |
| Tangible Book Value Per Share | -0.06 | -0.08 | -0.08 | -0.06 | -0.05 |
| Shareholders’ Equity Per Share | -0.06 | -0.07 | -0.07 | -0.06 | -0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.00 | 0.00 | -0.00 | -0.07 |
| Revenue Per Share | 0.87 | 0.61 | 0.37 | 0.34 | 0.31 |
| Net Income Per Share | 0.00 | -0.01 | -0.03 | -0.02 | -0.01 |
| Tax Burden | 0.78 | 1.00 | 1.00 | 1.00 | 1.07 |
| Interest Burden | 0.83 | 3.47 | 1.09 | 1.21 | 1.48 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.34 | 0.41 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.05 | 0.04 | 0.05 |
| Income Quality | 4.38 | -2.12 | 0.09 | 0.66 | -0.70 |
Currency in USD
